Generex Biotechnology Creates Scientific Advisory Board to Further the Progression of Its Drug Development Programs
02 août 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., Aug. 2, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the...
Generex Announces AGM Results
30 juil. 2010 16h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., July 30, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced the results of the Company's annual meeting of stockholders held...
Generex Provides Positive Update On Generex Oral-Lyn(TM) Pivotal Phase III Trial
28 juil. 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., July 28, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex's Glucose RapidSpray(TM) Now Available at Boots UK Retail Chain Stores
15 juil. 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., July 15, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Announces Receipt of Favorable NASDAQ Listing Determination
15 juil. 2010 07h34 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., July 15, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced its receipt of a decision by the NASDAQ Listing Qualifications...
Generex Oncology Granted United States Patent for AE37 Peptide Vaccine
13 juil. 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., July 13, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (Nasdaq:GNBT) today announced that its wholly-owned subsidiary, Antigen Express, Inc....
Generex Biotechnology Participates in Gateway to China Business Round Table Conference
07 juil. 2010 12h18 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., July 7, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (Nasdaq:GNBT) today announced its participation in the Gateway to China Business Round Table...
Generex Biotechnology to Participate in World's Largest and Most Prestigious Diabetes Meeting
22 juin 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., June 22, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (Nasdaq:GNBT) today announced its participation as an exhibitor during the 70th Scientific...
Generex Oncology Announces Presentations at the American Society of Clinical Oncology Annual Meeting and the 7th World Vaccine Conference
09 juin 2010 09h27 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., June 9, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced presentations on the technologies and products under development at...
Generex Biotechnology Reports Preliminary Outcomes and Trends From Ongoing Phase III Clinical Trial of Generex Oral-lyn(TM)
07 juin 2010 09h55 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., June 7, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the...